IA
DAWN

Inspire Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History

Inspire Advisors’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,681
Closed -$508K – 749
2026
Q1 		$508K Buy
+23,681
New +$334K 0.04% 358

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Inspire Advisors's DAWN Position: Q2 2026 in Review

Inspire Advisors sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 23,681 shares — an estimated $508K sold.

Inspire Advisors first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $508K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Inspire Advisors reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Inspire Advisors sold 23,681 Day One Biopharmaceuticals shares in Q2 2026, an estimated $508K.
  • Inspire Advisors first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Inspire Advisors's Day One Biopharmaceuticals position peaked at $508K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.